Authors:
Delaugerre, C
Valantin, MA
Mouroux, M
Bonmarchand, M
Carcelain, G
Duvivier, C
Tubiana, R
Simon, A
Bricaire, F
Agut, H
Autran, B
Katlama, C
Calvez, V
Citation: C. Delaugerre et al., Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure, AIDS, 15(16), 2001, pp. 2189-2191
Authors:
Rollot, F
Bossi, P
Tubiana, R
Caumes, E
Zeller, V
Katlama, C
Bricaire, F
Citation: F. Rollot et al., Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy, AIDS, 15(11), 2001, pp. 1448-1449
Authors:
Jouan, M
Saves, M
Tubiana, R
Carcelain, G
Cassoux, N
Aubron-Olivier, C
Fillet, AM
Nciri, M
Senechal, B
Chene, G
Tural, C
Lasry, S
Autran, B
Katlama, C
Citation: M. Jouan et al., Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy, AIDS, 15(1), 2001, pp. 23-31
Authors:
Carcelain, G
Tubiana, R
Samri, A
Calvez, V
Delaugerre, C
Agut, H
Katlama, C
Autran, B
Citation: G. Carcelain et al., Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection, J VIROLOGY, 75(1), 2001, pp. 234-241
Authors:
Girard, PM
Pegram, PS
Diquet, B
Anderson, R
Raffi, F
Tubiana, R
Sereni, D
Boerner, D
Citation: Pm. Girard et al., Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection:Pharmacokinetics, tolerability, and efficacy, J ACQ IMM D, 23(3), 2000, pp. 227-235
Authors:
Combadiere, B
Blanc, C
Li, TS
Carcelain, G
Delaugerre, C
Calvez, V
Tubiana, R
Debre, P
Katlama, C
Autran, B
Citation: B. Combadiere et al., CD4(+)Ki67(+) lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle, EUR J IMMUN, 30(12), 2000, pp. 3598-3603
Citation: R. Tubiana et P. Chamagne, Prolonged rehabilitation treatment of musician's focal dystonia, MEDICAL PROBLEMS OF THE INSTRUMENTALIST MUSICIAN, 2000, pp. 369-378
Authors:
Li, TS
Tubiana, R
Fillet, AM
Autran, B
Katlama, C
Citation: Ts. Li et al., Negative result of cytomegalovirus blood culture with restoration of CD4(+) T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient, J ACQ IMM D, 20(5), 1999, pp. 514-515
Authors:
Mouroux, M
Bossi, P
Yvon-Groussin, A
Delaugerre, C
Valantin, MA
Tubiana, R
Coutellier, A
Bonmarchand, M
Bricaire, F
Katlama, C
Agut, H
Huraux, JM
Calvez, V
Citation: M. Mouroux et al., Protease gene polymorphism in HIV-1-infected patients and response to therapy including a protease inhibitor., PATH BIOL, 47(5), 1999, pp. 549-552
Authors:
Renaud, M
Katlama, C
Mallet, A
Calvez, V
Carcelain, G
Tubiana, R
Jouan, M
Caumes, E
Agut, H
Bricaire, F
Debre, P
Autran, B
Citation: M. Renaud et al., Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen, AIDS, 13(6), 1999, pp. 669-676
Authors:
Neumann, AU
Tubiana, R
Calvez, V
Robert, C
Li, TS
Agut, H
Autran, B
Katlama, C
Citation: Au. Neumann et al., HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment, AIDS, 13(6), 1999, pp. 677-683
Authors:
Sereni, D
Tubiana, R
Lascoux, C
Katlama, C
Taulera, O
Bourque, A
Cohen, A
Dvorchik, B
Martin, RR
Tournerie, C
Gouyette, A
Schechter, PJ
Citation: D. Sereni et al., Pharmacokinetics and tolerability of intravenous Trecovirsen (GEM (R) 91),an antisense phosphorothioate oligonucleotide, in HIV-positive subjects, J CLIN PHAR, 39(1), 1999, pp. 47-54